Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

FuelCell Energy

Nikola

Some penny stocks go on to deliver huge returns for their owners. Most, however, do not.

3 Penny Stocks to Sell in September Before They Crash & Burn

Aurora Cannabis

Tilray Brands

Aurora Cannabis is paying down debt -- and promising positive free cash flow (FCF) in 2024. Wall Street analysts don't think the company will be FCF-profitable before 2026.

Why Canopy Growth, Aurora Cannabis, and Tilray Stocks All Exploded Higher Today

The positive performance of cannabis stocks last week driven by enthusiasm around the potential rescheduling of marijuana as a lower-risk drug in the U.S. is set to continue as progress is made on cannabis banking reform in the country, according to analysts at Water Tower Research.

Cannabis MSO winning streak expected to continue as lawmakers vote on SAFE Banking Act

Canopy Growth (NASDAQ: CGC ) stock fans will want to check in on the company when Sept. 25 rolls around for a potential catalyst.

Dear CGC Stock Fans, Mark Your Calendars for Sept. 25

SNDL Inc.

It might not seem like penny stocks and Twinkies go together. But with the latest surge in marijuana stocks, Hostess stock might not be the worst complement to the cannaboom in 2023.

3 Marijuana Penny Stocks To Watch After Hostess Stock News

Shares of Canopy Growth Corporation (TSX:WEED, NYSE:CGC) had added almost 50% on Monday morning, sending its share price back above $1, as cannabis stocks continued to benefit from the news that U.S. health officials have recommended the re-scheduling of marijuana as a lower-risk drug.

Canopy Growth and other pot stocks surge on marijuana rescheduling optimism

Canopy Growth (NASDAQ: CGC) stock price has made a strong comeback in the past few days as investors cheer some good news about the pot industry. The shares rose above $1 for the first time since June this year.

Canopy Growth stock price could double to $2 but risks remain

Shareholders are Encouraged to Vote Well in Advance of the Proxy Deadline of 1:00 p.m. (Eastern time) on September 21, 2023 Your Vote is Important!

Canopy Growth Reminds Shareholders to Cast Their Vote for Upcoming Annual General and Special Meeting of Shareholders to be held on September 25, 2023 at 1:00 p.m. (Eastern time)

Canopy Growth Corp. CGC, +22.61% stock was up 9.5% in premarket trades Monday, to put it on track to trade above $1 for the first time since May. The gain comes after a nearly 23% rally in the previous session to finish out a strong week for cannabis stocks.

Canopy Growth stock trades above $1 for first time since May

Curaleaf Holdings, Inc.

IM Cannabis Corp

With cannabis usage continuing to rise, now could be an opportune time to invest in marijuana stocks. Over 52 million Americans currently use cannabis, and legalization seems inevitable as more states approve recreational and medical use.

The 3 Best Cannabis Stocks to Buy Now: September 2023

Momentum for passage of marijuana reform legislation keeps growing, and senators are confident the SAFE Banking Act will pass. A new study touts the benefits of medical marijuana for pain amelioration.

Why Canopy Growth, Aurora Cannabis, and Curaleaf Stocks All Popped Today

Shares of Canopy Growth Corp. CGC, +22.72% shot up 21.7% toward a near four-month high in very active afternoon trading, putting them on track for the fifth double-digit percentage gain in seven sessions. The stock has rocketed 130% over the past seven session.

Canopy Growth stock soars on heavy volume again, amid cannabis investor optimism over possible favorable legislation

Cronos Group

Marijuana penny stocks and higher-priced cannabis stocks are having a moment in the stock market right now. Mainstream stock market news is about inflation being high, and considered a negative.

Marijuana Penny Stocks Are On Fire, 3 To Watch Right Now

The recent bull run on the Canadian pot purveyor ended, following news of insider share sales. Three members of the board of directors unloaded pieces of their holdings.

Why Canopy Growth Stock Tanked Today

Green Thumb Industries Inc.

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Cannabis stocks advanced Thursday, helped by news that a key Senate committee could soon vote to advance a widely followed bill that aims to make it easier for the financial industry to work with cannabis companies.

Cannabis stocks gain as banking bill finds traction in Senate, but House OK looks challenging

AFC Gamma

Cannabis stocks may be some of the most controversial investing ideas. Yet, they could also become some of the most profitable.That reality may happen if cannabis can be rescheduled and federally legalized.

Investing in Cannabis Stocks? 3 Marijuana Companies That Could Get a Massive Rescheduling Boost

Village Farms International

We're glad you're here to learn about this week's top marijuana stocks, poised to see significant increases in September 2023. As the cannabis industry evolves, savvy investors seek opportunities while considering risk. This study combines technical analysis with lessons from the rapidly expanding cannabis industries in the United States and Canada.

Green Investments: Top Canadian Marijuana Stocks for September 2023

Over the weekend, the White House threw its support behind legalizing medical marijuana. Yesterday, the Senate Majority Leader said he will push for marijuana banking reform.

Why Canopy Growth Stock Keeps On Growing

Easterly Government Properties

Harte Hanks

Philip Morris

Constellation Brands

Stocks that deal in cannabis are rising as the U.S. government moves toward re-classifying marijuana. The Department of Health and Human Services (HHS) has asked the Drug Enforcement Administration (DEA) to consider moving marijuana from Schedule I to Schedule III.

Why Are Cannabis Stocks Still Up Today?

Innovative Industrial Properties

Chicago Atlantic Real Estate Finance

Curaleaf Holdings Inc. OTCMKTS: CURLF,  Innovative Industrial Properties Inc. NYSE: IIPR and Tilray Inc. NASDAQ: TLRY were among cannabis stocks jumping higher after the Department of Health and Human Services recommended that marijuana no longer be classified as a Schedule 1 drug.

Will This New Development Mean A Big Rally In Cannabis Stocks?

Cannabis stocks have come roaring back on recent news of major decriminalization progress at the federal level. The big question now for anyone who owns marijuana stocks or is considering the sector: Is there more upside left?

Cannabis stocks are still a buy despite recent double-digit gains

Last month, the Department of Health and Human Services suggested easing regulations on marijuana use. The Drug Enforcement Agency has final say on that -- but its boss, President Joe Biden, now says he supports medical marijuana legalization.

Why Marijuana Stocks Keep Growing Higher Tuesday

OrganiGram Holdings Inc.

Trulieve Cannabis Corp.

Cannabis stocks continued to move higher following the Labor Day long weekend after the U.S. Department of Health and Human Services (HHS) last week recommended reclassifying marijuana as a lower-risk drug.

Cannabis stock rally continues on marijuana rescheduling hopes

Canopy Growth Corporation's stock price rallied nearly 50% based on the news that the US Department of Health and Human Services recommended rescheduling cannabis to Schedule III. Other Canadian cannabis LPs and US cannabis support stocks also saw rallies, with Tilray, Village Farms, and Grow Generation all experiencing gains. The rescheduling of cannabis and the passage of the Safe Banking Act could lead to a larger cannabis stock rally and benefit US multi-state cannabis operators.

Canopy Growth Rallies On Possible Rescheduling Of Cannabis: Time To Buy

Cannabis stocks are on track to finish the week higher boosted by the news that the U.S. Department of Health and Human Services (HHS) has recommended reclassifying marijuana as a lower-risk drug.

News for Canopy Growth Stock (CGC)